News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
AMD Invests in Drug-Discovery Company Absci in Push to Sell AI Chips
Absci, a drug discovery company based in Vancouver, Washington, secured a $20 million investment from Advanced Micro Devices (AMD) to integrate the company’s AI chips
Seattle genomics startup Variant Bio signs deal with Novo Nordisk worth up to $50M
Seattle-based Variant Bio announced a multi-year partnership with Novo Nordisk for using genomic information in treating metabolic diseases such as obesity and diabetes, totaling up
How brain-mapping research by Seattle scientists could help prevent Alzheimer’s
Researchers at Seattle’s Allen Institute for Brain Science have uncovered which cell types are most sensitive to aging, a discovery that could revolutionize the development
Seattle research nonprofit shares in up to $52 million award for AI-powered disease prevention
Research nonprofits Phenome Health and the Buck Institute have secured up to $52 million from the Advanced Research Projects Agency for Health. The funds will
For Nobel Prize winner David Baker, it’s back to the lab as protein pioneer helps launch more startups
After accepting the Nobel Prize award in chemistry, David Baker is eager to return to his lab at the University of Washington to continue paving
Why former Merck VP left big biotech for this Seattle startup
Scott Lesley, the president and chief scientific officer of InduPro, reflects on his decision to leave Merck & Co. to lead the Seattle-based startup and
Three Spokane Based Companies, One Seattle Based Company, and SRHD Receive HSSA Matching Grants for Bioscience Based Economic Development
The Health Sciences and Services Authority of Spokane County (HSSA) has awarded matching grants for bioscience-based economic development to three Spokane-based companies, one Seattle-based company
Executive Perspective: Harnessing Potent Molecules to Fight Cancer
Linda Liang, Senior Director of Antibody Discovery at Bonum Therapeutics in Seattle, Washington breaks down her work on developing potent molecules to fight cancer and
Seattle biotech company lands $16.5 million award for disease test
Seattle-based InBios International, a biotech focused on the development of diagnostic tests for infectious diseases, received a $16.5 million award from the Biomedical Advanced Research
Milk-based therapies could be coming. This biotech CEO is aiming to lead the way.
Intrinsic Medicine, a Seattle-based biotech, is developing human milk oligosaccharide (HMO) drugs to treat a range of gut immune microbiota brain axis disorders, with its
Top 10 Spatial Biology Companies of 2024
LSW members RareCyte and Alpenglow Biosciences were ranked among the top 10 spatial biology companies of 2024. In June, RareCyte completed a $20 million financing
Uncommon Thinkers: Ingrid Swanson Pultz devotes herself to improving lives through protein design
Dr. Ingrid Swanson Pultz, a trailblazer in protein design, began her career at the University of Washington with a passion for creating innovative biological solutions.